Stroke survivors often face a long road back to daily life. A new analysis of nearly 5,000 patients found that adding Tongxinluo capsule to standard care helps them regain independence faster. This treatment showed clear benefits in helping people perform daily tasks and reduced neurological impairment scores. The study looked at patients with acute ischemic stroke, a common type of stroke caused by a blocked blood vessel. The results were consistent across different measures of recovery and daily function. Importantly, the medication did not increase the risk of death or overall side effects. Patients taking the capsule alongside usual care did not experience more problems than those on placebo or standard treatment alone. The data suggests this approach offers a safe way to support recovery. While the study is a review of existing trials, the findings provide a clearer picture of what this medicine can do. For patients and families, the message is hopeful but grounded: there is a tool that may help restore function without adding danger. The focus remains on real-world outcomes like walking, eating, and living independently again.
Meta-analysis finds Tongxinluo capsule may improve functional outcomes in acute ischemic strokeTongxinluo capsule helps stroke survivors regain independence without added risk
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider that Tongxinluo capsule may improve functional outcomes in acute ischemic stroke, but mortality benefit is uncertain.
This systematic review and meta-analysis evaluated the association between Tongxinluo capsule and outcomes in patients with acute ischemic stroke. Across studies totaling 4,842 participants, the intervention was compared with placebo or usual care. The primary outcome was long-term functional independence, defined as a modified Rankin Scale score less than 2.
The meta-analysis found that Tongxinluo capsule was associated with improved long-term functional independence (RR, 1.21; 95% CI, 1.02 to 1.44). Secondary outcomes also favored the intervention: activities of daily living improved (Barthel Index mean difference, 11.47; 95% CI, 10.34 to 12.60) and neurological impairment decreased (NIHSS mean difference, 3.48; 95% CI, 2.87 to 4.09). All-cause mortality did not differ significantly (RR, 0.57; 95% CI, 0.17 to 1.95), and the incidence of overall adverse events was similar (RR, 1.01; 95% CI, 0.91 to 1.12).
The authors note that serious adverse events and discontinuations were not reported, and tolerability was described without observing major safety concerns. The analysis is limited by heterogeneity across included studies, variations in treatment protocols, and potential publication bias, which were not fully quantified in this summary. Follow-up duration and specific study settings were not reported.
In practice, these findings suggest a possible benefit for functional outcomes, but they do not establish causality. Clinicians should interpret the results cautiously, considering the quality of the underlying trials and the absence of mortality benefit, before integrating Tongxinluo capsule into routine care.
What this means for you:
Tongxinluo capsule improves daily function and safety for stroke patients in this analysis. More on Stroke
Individualized six-phase antithrombotic strategy leads to left ventricular thrombus resolution and neurological recovery
New strategy helps manage heart blood clots after heart attack
This case report describes an individualized six-phase antithrombotic strategy for a 27-year-old male with myocardial infarction, stroke, hy…
A tailored six-phase treatment plan helped a young man recover fully from a stroke and heart attack while successfully clearing dangerous bl…
Mind-body training improves upper-limb function after stroke, optimal dose near 33.5 hours
Mind body training improves arm function for stroke survivors
This meta-analysis of 16 RCTs (769 participants) found that mind-body training (MBT), including Tai Chi, significantly improves upper-limb f…
New data shows that mind body exercises like Tai Chi can significantly improve arm movement and function for people recovering from a stroke…
Tirofiban Adjunct Therapy Improves Outcomes in Patients with Inadequate Tenecteplase Response
Trial shows tirofiban improves outcomes for some stroke patients
Intravenous tirofiban significantly improves 90-day functional outcomes for acute ischemic stroke patients failing initial tenecteplase ther…
A new clinical trial suggests that adding tirofiban can improve recovery rates for certain types of stroke patients who do not respond well …
Acupuncture shows consistent signals for dysphagia and depressive symptoms after ischemic stroke
Acupuncture May Help Stroke Patients with Swallowing and Mood
This narrative review synthesizes evidence on acupuncture for ischemic stroke. It finds more consistent signals for dysphagia and depressive…
New research suggests acupuncture may specifically help stroke patients manage swallowing difficulties, depression, and cognitive issues.
View Original Abstract ↓
ETHNOPHARMACOLOGICAL RELEVANCE: Tongxinluo capsule is widely used in patients with acute ischemic stroke (AIS), although the literature does not consistently agree on its efficacy and safety.
AIM OF THE STUDY: We aimed to assess the efficacy and safety of Tongxinluo capsule for patients with AIS.
MATERIALS AND METHODS: A systematic search of the databases PubMed, Embase, Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, Wanfang data, VIP Chinese Journal Service Platform, and SinoMed was conducted from their inception dates to January 2025. Randomized controlled trials (RCTs) that enrolled patients with AIS who receive Tongxinluo capsule and compared effects with placebo or as an add-on therapy to usual care were included. Literature screening, risk of bias assessment, and data extraction were independently conducted in duplicate. Fixed-effects or random-effects models were used to perform meta-analysis for pooling data from eligible studies. The primary outcome was long-term functional independence (defined as modified Rankin Scale [mRS] grade less than 2). Secondary outcomes included all-cause mortality, improvements in activities of daily living (measured with the Barthel Index [BI]), and neurological impairment (measured with the National Institutes of Health Stroke Scale [NIHSS]). Incidence of adverse events were identified as safety outcomes.
RESULTS: We included 4842 patients with AIS from 12 RCTs (2422 [50.02 %] treated with Tongxinluo capsule) in the final analysis. Tongxinluo capsule treatment in AIS significantly improved the proportion of patients with mRS less than 2 (RR, 1.21; 95 % CI, 1.02 to 1.44), improved the change in BI score (MD, 11.47; 95 % CI, 10.34 to 12.60) and NIHSS score (MD, 3.48; 95 % CI, 2.87 to 4.09). No significant differences were detected in all-cause mortality (RR, 0.57; 95 % CI, 0.17 to 1.95), or the incidence of overall adverse events (RR, 1.01; 95 % CI, 0.91 to 1.12).
CONCLUSION: Administration of Tongxinluo capsule for AIS demonstrated potential benefits in improving the long-term functional outcomes and activities of daily living, and relieving neurological impairment, without observing major safety concerns.
Intravenous tenecteplase improves functional outcomes but increases hemorrhage risk in non-large vessel occlusion acute ischemic stroke
Tenecteplase improves stroke recovery but increases bleeding risk in late treatment window
Related in Neurology
Rapid advancements in imaging and blood-based biomarkers are transforming the diagnosis and management of ADRD
New guidelines help doctors tell delirium from dementia
This clinical guideline provides a narrative review on the evolving diagnostic and treatment landscape for Alzheimer's disease and related d…
Delirium is acute and fluctuating; dementia is chronic. New guidelines help doctors tell them apart.
ACTH and vigabatrin achieved full seizure control in a patient with Ververi-Brady syndrome
ACTH and Vigabatrin Show Promise for Rare Epilepsy Syndrome
This case report describes a 5-month-old male infant with Ververi-Brady syndrome and infantile epileptic spasms syndrome. The patient achiev…
A new gene variant linked to Ververi-Brady syndrome showed positive results when treated with a combination of ACTH and vigabatrin.
Aging impacts multiple sclerosis pathobiology by shifting inflammation toward chronic, compartmentalized neuroinflammation and neurodegeneration
New research explores how aging changes multiple sclerosis treatment
This narrative review examines the impact of aging on the immunological and neuroinflammatory microenvironment in older patients with multip…
As people age, multiple sclerosis can change from sudden flare-ups to a slow, steady progression of nerve damage.
Tirofiban Adjunct Therapy Improves Outcomes in Patients with Inadequate Tenecteplase Response
Trial shows tirofiban improves outcomes for some stroke patients
Intravenous tirofiban significantly improves 90-day functional outcomes for acute ischemic stroke patients failing initial tenecteplase ther…
A new clinical trial suggests that adding tirofiban can improve recovery rates for certain types of stroke patients who do not respond well …
From Other Specialties
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …
Postoperative AKI occurs in half of type A aortic dissection surgeries, meta-analysis finds
Factors Linked to Kidney Injury After Aortic Dissection Surgery
This meta-analysis of 44 studies (11,983 patients) found that 50.72% of patients undergoing surgery for Stanford type A aortic dissection de…
Over half of patients undergoing surgery for a specific type of aortic dissection develop acute kidney injury, with several risk factors ide…
Social and emotional skills training shows non-significant reductions in loneliness among children and adolescents
Social and Emotional Training Shows Promise for Youth Loneliness
This meta-analysis of 18 studies evaluated interventions targeting loneliness, including social and emotional skills training, in youth aged…
New research looks at how social and emotional skills training can help reduce feelings of loneliness in children and teenagers.